We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Now I have solid data. Let me identify the biggest names from the full earnings week ahead results and write the article:

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Now I have solid data. Let me identify the biggest names from the full earnings week ahead results and write the article:

Big Week Ahead for Earnings

Over 1,800 companies are set to report this week. The calendar is packed from Monday through Sunday.

Today (Monday, May 4), CNA Financial and Loews Corporation both report. Corebridge Financial releases results after the close. BioMarin Pharmaceutical holds its earnings call at 4:30pm ET.

Tomorrow (Tuesday), Alkermes kicks off the session with an 8am call. AudioCodes reports at 8:30am. Bright Horizons Family Solutions releases numbers after the bell.

Wednesday brings a heavy slate. Cencora calls at 8:30am. Flex and Clean Harbors both report mid-morning. Albemarle, the lithium miner closely watched for EV demand signals, posts after the close. Cognex and Cirrus Logic also report Wednesday.

Thursday, Akamai Technologies holds its call at 4:30pm ET. Bentley Systems reports in the morning. AMN Healthcare and Callaway Golf post results after the bell.

Friday, The Wendy's Company and Dauch Corporation wrap up the week.

No major IPOs are scheduled in the next seven days based on available data.

How this article was generated

Generated
4 May 2026, 12:31
Prompt version
migrated
Data sources
EarningsAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.